Glycogen Phosphorylase, Glycogen Debranchin

Total Page:16

File Type:pdf, Size:1020Kb

Glycogen Phosphorylase, Glycogen Debranchin Glycogen metabolism Subtopics Introduction Degradation of glycogen: glycogen phosphorylase, glycogen debranching enzyme, phosphoglucomutase and glucose-6 phosphatase Glycogen synthesis: UDP-glucose pyrophosphorylase, glycogenin, glycogen synthase, glycogen branching enzyme and significance of glycogen branching Thermodynamics of glycogen metabolism Control of glycogen metabolism: allosteric regulation and bicyclic cascade of glycogen phosphorylase and glycogen synthase Integration of glycogen metabolism: cAMP-dependent phosphorylation cascade (G-proteins, adenylate cyclase, protein kinase A, phosphorylase kinase) and calcium-dependent phosphorylation cascade (Calmodulin and phosphorylase kinase) Signal amplification and signal termination by phosphoprotein phosphatase 1 Insulin and the well-fed state, maintenance of blood glucose level and glucose transporters (GLUT1-GLUT5) Glucagon and the fasting state Epinephrine and the stress response, the fructose-2,6-bisphosphate control system Glycogen storage diseases: Deficiencies of G6Pase, glucosidase, debranching enzyme, branching enzyme and muscle phosphorylase. 1 | P a g e Glycogen metabolism Introduction Glucose cannot be stored because high concentrations of glucose disrupt the osmotic balance of the cell. Higher organisms protect themselves from potential fuel shortage and osmotic damage by polymerizing excess glucose into glycogen. Glycogen is a high molecular weight storage polymer of glucose that can be readily mobilized in times of metabolic demand. It is predominantly α (1→4)-linked glucose polymer with α (1→6) branches every 8 to 14 residues. Glycogen is stored as large cytoplasmic particles in the form of hydrated granules. These cytoplasmic granular particles contain the enzymes that metabolize glycogen, as well as the machinery for regulating these enzymes. Glycogen forms a left- handed helix with 6.5 glucose residues per turn, similar to α-amylose. No matter how big, glycogen has but one reducing end. Glucose units from glycogen are mobilized by their sequential removal from their nonreducing ends. Storing energy as glucose polymers is common to all forms of life. It is present in eukaryotes, bacteria and archae. In plants, the glucose storage substance is starch. Glucose released from glycogen, unlike triacylglycerols from lipids, can be metabolized in the absence of oxygen and thus it can supply energy for anaerobic activity. Glycogen is a preferred source of energy for sudden, strenuous activity of muscles which cannot mobilize fats as rapidly as glycogen. The fatty acid residues of lipids cannot also be catabolized anaerobically. Furthermore, animals cannot convert fatty acids to glucose so fat metabolism alone cannot adequately maintain essential blood glucose levels. The two major storage tissues for glycogen storage in animals are the liver and skeletal muscles. Liver glycogen serves as a reservoir of glucose for other tissues when dietary glucose is not available. It maintains glucose homeostasis of the organism as a whole. In mammals, the neurons of brain have virtually no stored source of energy and they cannot use fatty acids as fuel. They are rather completely dependent on a constant supply of glucose from the blood. The circulating blood keeps the brain supplied with glucose, which is virtually the only fuel used by the brain, except during prolonged starvation. Hence glycogen in the liver is especially important to maintain the blood-glucose levels as required to meet the needs of the organism as a whole. In contrast, glycogen in muscle is utilized to meet the energy needs of only the selfish muscle. Muscle glycogen serves as a reservoir for muscle cells to provide a quick source of energy for either aerobic or anaerobic metabolism. Muscle contraction is driven by generating ATP through glycolysis of glucose. Muscle glycogen can be exhausted in less than 2 | P a g e an hour during vigorous activity. The enzymes in liver and muscle differ in subtle yet important ways that reflect the different roles of glycogen in the two tissues. Glycogen breakdown Glycogenolysis or glycogen breakdown is a catabolic pathway from glycogen to glucose-6-phosphate. It provides the energy essential to oppose the forces of entropy and biosynthetic precursors. Glycogen degradation comprises three steps catalyzed by three enzymes: the release of glucose-1-phosphate from glycogen by glycogen phosphorylase, glycogen remodeling by glycogen debranching enzyme and the conversion of glucose-1-phosphate (G1P) into glucose-6-phosphate (G6P) by phosphoglucomutase. Glycogen phosphorylase (or phosphorylase) catalyzes the sequential removal of glucosyl residues from the nonreducing ends of the glycogen substrate by the addition of orthophosphate (Pi) to yield G1P. It hydrolyzes α (1→4)-linked glucosyl units. The cleavage of a bond through the addition of a phosphate group is referred as phosphorolysis or phosphorolytic cleavage. Phosphorylase can only release a glucose unit that is at least five units from a branch point. Two activities are required to remodel glycogen by converting the branched structure into a linear form and permit further degradation by glycogen phosphorylase. These are a transferase and α-1,6-glucosidase activities. Glycogen debranching enzyme removes glycogen’s branches to allow the phosphorylase reaction to go to completion. It catalyzes both the transfer of three-residue chains onto the nonreducing ends of other chains and the hydrolysis of the remaining α(1→6)-linked glucosyl unit to yield glucose. The cleavage of a bond by addition of water is called hydrolysis or hydrolytic cleavage. Phosphorolysis of glycosidic bonds differs from hydrolysis by amylase during intestinal degradation of dietary glycogen and starch. In phosphorolysis, some of the energy of the glycosidic bond is preserved in the formation of the phosphate ester in G1P. G1P released from glycogen breakdown can be readily converted into G6P by phosphoglucomutase. G6P is suitable form for further metabolism. A. Glycogen phosphorylase Glycogen phosphorylase catalyzes the cleavage of an α(1→4) glycosidic bond between two glucose residues at any nonreducing end of glycogen. The reaction removes the terminal glucose residue as α-D- G1P through attack by inorganic phosphate (Pi). It catalyzes the controlling step in glycogen breakdown. Phosphorylase is a dimer of two identical subunits localized in the cytosol. Each subunit is compactly folded into an amino-terminal domain with a glycogen-binding site and a carboxyl-terminal domain. Phosphorylase is regulated both by both allosteric interactions and post-translational modification. Each 3 | P a g e subunits of the phosphorylase dimer can interconvert between a less active tensed (T) state and a more active relaxed (R) state. The T state is less active because the catalytic site is partly blocked by a loop. Allosteric inhibitors of phosphorylase such as ATP, G6P, and glucose favor the formation of the T state whereas allosteric activator such AMP favors the formation of the R-state. Covalent modification by phosphorylation on Ser-14 of each subunit favors the structure of the R state. Phosphorylase exists in two types of interchangeable conformers: phosphorylase b (catalytically inactive) and phosphorylase a (catalytically active). Both forms undergo equilibrium between the T and R states in which the unmodified form exist predominantly in the T state whereas the phosphorylated form exists predominantly in the R state. Allosteric regulators interact differently with the phospho- and dephosphoenzymes. Moreover, there are two isozymic forms of glycogen phosphorylase encoded by different genes: one specific to liver and one specific to skeletal muscle. In human beings, the liver and muscle forms are approximately 90% identical in amino acid sequence, yet the 10% difference results in subtle but important shifts in the stability of different forms of the enzyme. The a-form in liver can be reverted to the low-activity T state upon binding of glucose to its active site. The a-form in liver functions as glucose sensor. On the other hand, the b form in muscle can be activated by the binding of AMP, an effect counteracted by ATP and glucose 6-phosphate. Glycogen phosphorylase provides a clear example of the use of enzymatic isoforms to establish tissue-specific regulatory properties. The special challenge in the glycogen phosphorylase reaction is the exclusion of water from the active site. To this end, phosphorylase contains pyridoxal-5’-phosphate (PLP) group which functions as an essential cofactor. PLP is a derivative of pyridoxine (vitamin B 6). The aldehyde group of PLP forms a Schiff-base linkage with a Lys 680 of the enzyme. It is similarly linked to a variety of enzymes involved in transamination reactions. A Schiff base, also called an imine, is formed by the reaction of a primary amine with an aldehyde or ketone to produce a carbon–nitrogen double bond. The glycogen-binding site of phosphorylase is 30 Å away from the catalytic site on the surface which is connected to the catalytic site by a narrow crevice that can accommodate four or five sugar residues in a chain. However, this crevice is too narrow to admit branched oligosaccharides. The large separation between the substrate binding site and the catalytic site allows the enzyme to cleave many residues before the enzyme must bind the glycogen substrate again. An enzyme that can catalyze many reactions without having to dissociate and reassociate after each catalytic cycle is said to
Recommended publications
  • The Effects of Acute Nicotinamide Riboside Supplementation
    THE EFFECTS OF ACUTE NICOTINAMIDE RIBOSIDE SUPPLEMENTATION ON SUBSTRATE UTILISATION AND 5KM TIME-TRIAL PERFORMANCE By ELIZABETH LOUISE GRAY A thesis submitted to The University of Birmingham for the degree of MASTERS BY RESEARCH School of Sport, Exercise and Rehabilitation Sciences College of Life and Environmental Studies University of Birmingham August 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Nicotinamide Riboside (NR) administration has been shown to increase fat oxidation and improve endurance performance in rodents, whilst recent research has proven it is safe for human consumption. The present study aimed to investigate the influence of acute NR supplementation on substrate utilisation and exercise performance in humans. In this counter-balanced, crossover design study, eleven recreationally-active males performed a 60-minute bout of cycling at 55% VO2max, followed by a 5km time-trial. Participants completed this twice during visits separated by at least one week, once following the consumption of 1000mg NR, and the other following placebo consumption. The contribution of fat oxidation to total substrate utilisation was not significantly different between the NR and placebo conditions during steady-state exercise (22.3±9.0% and 19.6±7.3%, respectively; p < 0.05).
    [Show full text]
  • Chem331 Glycogen Metabolism
    Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate.
    [Show full text]
  • Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency
    Pediat. Res. 15: 299-303 (198 1) genetics muscle glycogenosis phosphorylase kinase deficiency liver Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency N. BASHAN. T. C. IANCU. A. LERNER. D. FRASER, R. POTASHNIK. AND S. W. MOSES'"' Pediatric Research Laborarorv. Soroka Medical Center. Iaculr~of Health Sciences. Ben-Gurion Universi!,' of Negev. Beer-Sheva, and Department of Pediatrics. Carmel Hospiral. Huifa. Israel Summary hepatomegaly. The family history disclosed that two sisters were similarly affected, whereas one older brother was apparently A four-year-old Israeli Arab boy was found to have glycogen healthy. accumulation in both liver and muscle without clinical symptoms. Past history was unremarkable. The patient's height was below Liver phosphorylase kinase (PK) activity was 20% of normal, the third percentile for his age in contrast to a normal weight. He resulting in undetectable activity of phosphorylase a. Muscle PK had a doll face and a protuberant abdomen. The liver was palpable activity was about 25% of normal, resulting in a marked decrease 9 cm below the costal margin. Slight muscular hypotonia and of phosphorylase a activity. weakness were noticeable with normal tendon reflexes. He had Two sisters showed a similar pattern, whereas one brother had slightly abnormal liver function tests. a fasting blood sugar of 72 normal PK activity. The patient's liver protein kinase activity was mg %, a normal glucagon test. and no lactic acidemia or uricemia normal. Addition of exogenous protein kinase did not affect PK but slight lipidemia. Electronmicroscopic studies of a liver biopsy activity, whereas exogenous PK restored phosphorylase activity revealed marked deposition of glycogen.
    [Show full text]
  • Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease
    cells Review Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease Marta Migocka-Patrzałek * and Magdalena Elias Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wroclaw, 50-335 Wroclaw, Poland; [email protected] * Correspondence: [email protected] Abstract: Glycogen phosphorylase (PG) is a key enzyme taking part in the first step of glycogenolysis. Muscle glycogen phosphorylase (PYGM) differs from other PG isoforms in expression pattern and biochemical properties. The main role of PYGM is providing sufficient energy for muscle contraction. However, it is expressed in tissues other than muscle, such as the brain, lymphoid tissues, and blood. PYGM is important not only in glycogen metabolism, but also in such diverse processes as the insulin and glucagon signaling pathway, insulin resistance, necroptosis, immune response, and phototransduction. PYGM is implicated in several pathological states, such as muscle glycogen phosphorylase deficiency (McArdle disease), schizophrenia, and cancer. Here we attempt to analyze the available data regarding the protein partners of PYGM to shed light on its possible interactions and functions. We also underline the potential for zebrafish to become a convenient and applicable model to study PYGM functions, especially because of its unique features that can complement data obtained from other approaches. Keywords: PYGM; muscle glycogen phosphorylase; functional protein partners; glycogenolysis; McArdle disease; cancer; schizophrenia Citation: Migocka-Patrzałek, M.; Elias, M. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease. Cells 1. Introduction 2021, 10, 883. https://doi.org/ The main energy substrate in animal tissues is glucose, which is stored in the liver and 10.3390/cells10040883 muscles in the form of glycogen, a polymer consisting of glucose molecules.
    [Show full text]
  • Lehrstuhl Für Technische Mikrobiologie Sucrose Metabolism
    Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr.-Ing., Dr.-Ing. habil. Werner Back Prüfer der Dissertation: 1. Univ.-Prof. Dr. rer. nat. habil. Rudi F. Vogel 2. Univ.-Prof. Dr. rer. nat. habil. Siegfried Scherer 3. Ass. Prof. Dr. rer. nat. Michael Gänzle, University of Alberta / Kanada (schriftliche Beurteilung) Die Dissertation wurde am 25.10.2007 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 07.01.2008 angenommen. Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Doctoral thesis Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt Freising 2008 Mein Dank gilt Rudi Vogel für die Überlassung des Themas und seine geduldige und unterstützende Begleitung durch die lehrreichen und interessanten Jahre, Michael Gänzle, Maher Korakli und Daniel Meissner für ihr Engagement und ihre Unterstützung, allen Kollegen für das gute und humorvolle Arbeitsklima, Andreas Stocker für die Charakterisierung des EPS mit FFF, Peter Kaden für die NMR- Analyse und Jürgen Behr für die Durchführung der 2D-Experimente,
    [Show full text]
  • O-Glcnacylation Is a Key Regulator of Multiple Cellular Metabolic Pathways
    O-GlcNAcylation is a key regulator of multiple cellular metabolic pathways Hongshuo Zhang, Zhen Li, Yufei Wang and Ying Kong Core Laboratory of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China ABSTRACT O-GlcNAcylation modifies proteins in serine or threonine residues in the nucleus, cytoplasm, and mitochondria. It regulates a variety of cellular biological processes and abnormal O-GlcNAcylation is associated with diabetes, cancer, cardiovascular disease, and neurodegenerative diseases. Recent evidence has suggested that O-GlcNAcylation acts as a nutrient sensor and signal integrator to regulate metabolic signaling, and that dysregulation of its metabolism may be an important indicator of pathogenesis in disease. Here, we review the literature focusing on O-GlcNAcylation regulation in major metabolic processes, such as glucose metabolism, mitochondrial oxidation, lipid metabolism, and amino acid metabolism. We discuss its role in physiological processes, such as cellular nutrient sensing and homeostasis maintenance. O-GlcNAcylation acts as a key regulator in multiple metabolic processes and pathways. Our review will provide a better understanding of how O-GlcNAcylation coordinates metabolism and integrates molecular networks. Subjects Biochemistry, Cell Biology, Metabolic Sciences Keywords O-GlcNAc, Nutrient sensing, Glucose uptake, Glycolysis, Mitochondria, Lipid metabolism, Glutamine, Signaling pathway, Homeostasis, TCA INTRODUCTION Increasing evidence has suggested
    [Show full text]
  • Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly
    International Journal of Molecular Sciences Article Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly 1,2, 3, 1,2, Alessandra Bolotta y, Giuseppe Filardo y, Provvidenza Maria Abruzzo *, Annalisa Astolfi 4,5 , Paola De Sanctis 1, Alessandro Di Martino 6, Christian Hofer 7, Valentina Indio 4 , Helmut Kern 7, Stefan Löfler 7 , Maurilio Marcacci 8, Sandra Zampieri 9,10, 1,2, 1, Marina Marini z and Cinzia Zucchini z 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna School of Medicine, 40138 Bologna, Italy; [email protected] (A.B.); [email protected] (P.D.S.); [email protected] (M.M.); [email protected] (C.Z.) 2 IRCCS Fondazione Don Carlo Gnocchi, 20148 Milan, Italy 3 Applied and Translational Research Center, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; g.fi[email protected] 4 Giorgio Prodi Interdepartimental Center for Cancer Research, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy; annalisa.astolfi@unibo.it (A.A.); [email protected] (V.I.) 5 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy 6 Second Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] 7 Ludwig Boltzmann Institute for Rehabilitation Research, 1160 Wien, Austria; [email protected] (C.H.); [email protected] (H.K.); stefan.loefl[email protected] (S.L.) 8 Department of Biomedical Sciences, Knee Joint Reconstruction Center, 3rd Orthopaedic Division, Humanitas Clinical Institute, Humanitas University, 20089 Milan, Italy; [email protected] 9 Department of Surgery, Oncology and Gastroenterology, University of Padua, 35122 Padua, Italy; [email protected] 10 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy * Correspondence: [email protected]; Tel.: +39-051-2094122 These authors contributed equally to this work.
    [Show full text]
  • Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis
    Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis Control of Glycogen Metabolism Glycogen Storage Diseases Glycogen Glycogen - animal storage glucan 100- to 400-Å-diameter cytosolic granules up to 120,000 glucose units α(1 → 6) branches every 8 to 12 residues muscle has 1-2% (max) by weight liver has 10% (max) by weight ~12 hour supply Although metabolism of fat provides more energy: 1. Muscle mobilize glycogen faster than fat 2. Fatty acids of fat cannot be metabolized anaerobically 3. Animals cannot convert fatty acid to glucose (glycerol can be converted to glucose) Glycogen Breakdown Three enzymes: glycogen phosphorylase glycogen debranching enzyme phosphoglucomutase Glycogen phosphorylase (phosphorylase) - phosphorolysis of glucose residues at least 5 units from branch point Glycogen + Pi glycogen + glucose-1-phosphate (n residues) (n-1 residues) homodimer of 842-residues (92-kD) subunits allosteric regulation - inhibitors (ATP, glucose-6- phosphate, glucose) and activator (AMP), T ⇔ R covalent modification (phosphorylation) - modification/demodification 2- phosphorylase a (active, SerOPO3 ) phosphorylase b (less active, Ser) narrow 30-Å crevice binds glycogen, accommodates 4 to 5 residues Pyridoxal-5-phosphate (vit B6 derivative) cofactor - located near active site, general acid-base catalyst Rapid equilibrium Random Bi Bi kinetics Glycogen Breakdown Glycogen debranching enzyme - possesses two activities α(1 → 4) transglycosylase (glycosyl transferase) 90% glycogen → glucose-1-phosphate transfers trisaccharide unit from
    [Show full text]
  • Association of Glycogen Synthase Phosphatase And
    ASSOCIATION OF GLYCOGEN SYNTHASE PHOSPHATASE AND PHOSPHORYLASE PHOSPHATASE ACTIVITIES WITH MEMBRANES OF HEPATIC SMOOTH ENDOPLASMIC RETICULUM Downloaded from http://rupress.org/jcb/article-pdf/83/2/348/1074048/348.pdf by guest on 26 September 2021 R . N . MARGOLIS, R . R . CARDELL, and R . T . CURNOW From the Departments of Anatomy, Internal Medicine, and Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908 ABSTRACT A detailed investigation was conducted to determine the precise subcellular localization ofthe rate-limiting enzymes of hepatic glycogen metabolism (glycogen synthase and phosphorylase) and their regulatory enzymes (synthase phosphatase and phosphorylase phosphatase) . Rat liver was homogenized and fractionated to produce soluble, rough and smooth microsomal fractions . Enzyme assays of the fractions were performed, and the results showed that glycogen synthase and phosphorylase were located in the soluble fraction of the livers . Synthase phos- phatase and phosphorylase phosphatase activities were also present in soluble fractions, but were clearly identified in both rough and smooth microsomal fractions . It is suggested that the location of smooth endoplasmic reticulum (SER) within the cytosome forms a microenvironment within hepatocytes that establishes conditions necessary for glycogen synthesis (and degradation) . Thus the location of SER in the cell determines regions of the hepatocyte that are rich in glycogen particles . Furthermore, the demonstration of the association of synthase phospha- tase and phosphorylase phosphatase with membranes of SER may account for the close morphological association of SER with glycogen particles (i .e ., disposition of SER membranes brings the membrane-bound regulatory enzymes in close contact with their substrates) . KEY WORDS smooth endoplasmic reticulum less clear .
    [Show full text]
  • Glycogen Metabolism CH2OH CH2OH Glycogen H O H H O H H H OH H OH H 1 O OH O H OH H OH
    Glycogen Metabolism CH2OH CH2OH glycogen H O H H O H H H OH H OH H 1 O OH O H OH H OH CH2OH CH2OH 6 CH2 CH2OH CH2OH H O HH O H H 5 O H H O H H O H H H H H H 1 4 OH H OH H 4 OH H OH H OH H O O O O OH OH 3 2 H OH H OH H OH H OH H OH Glycogen is a polymer of glucose residues linked by (14) glycosidic bonds, mainly (16) glycosidic bonds, at branch points. Glycogen chains & branches are longer than shown. Glucose is stored as glycogen predominantly in liver and muscle cells. CH2OH H O H H OH H 2 Glycogen catabolism OH OPO3 H OH (breakdown): glucose-1-phosphate Glycogen Phosphorylase catalyzes phosphorolytic cleavage of the (14) glycosidic linkages of glycogen, releasing glucose‐1‐phosphate as reaction product. glycogen(n residues) +Pi glycogen (n–1 residues) +glucose‐1‐phosphate This phosphorolysis may be compared to hydrolysis: Hydrolysis: R-O-R' + HOH R-OH + R'-OH 2- 2- Phosphorolysis: R-O-R' + HO-PO3 R-OH + R'-O-PO3 Pyridoxal phosphate (PLP), H O O C a derivative of vitamin B , O H2 6 PC OH serves as prosthetic group O O for Glycogen N CH3 Phosphorylase. H pyridoxal phosphate (PLP) lysine Enz H (CH2)4 H N+ CCOO 3 N+ CH O HC H 2 O H2 P C O CH2 O O CH2 CH2 N CH3 H NH3 Enzyme (Lys)-PLP Schiff base Pyridoxal phosphate (PLP) is held at the active site by a Schiff base linkage, formed by reaction of the aldehyde of PLP with the ‐amino group of a lysine residue.
    [Show full text]
  • Factors Influencing Glycogen Branching Enzyme Activity in Mouse
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2013 Factors influencing glycogen branching enzyme activity in mouse liver Scott ulF ler Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Kinesiology Commons Recommended Citation Fuller, Scott, "Factors influencing glycogen branching enzyme activity in mouse liver" (2013). LSU Doctoral Dissertations. 2022. https://digitalcommons.lsu.edu/gradschool_dissertations/2022 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. FACTORS INFLUENCING GLYCOGEN BRANCHING ENZYME ACTIVITY IN MOUSE LIVER A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Kinesiology by Scott Fuller B.A. Louisiana State University, 1993 M.P.A. Louisiana State University, 1998 M.S. Louisiana State University, 2005 May 2013 ACKNOWLEDGMENTS The completion of a dissertation is never the result of a single individual’s effort. Indeed, this project would never have been seen through to the end without the devotion, patience, and inspired ideas of several academic professionals whose dedication to scientific inquiry sustained this enterprise. First and foremost, I owe an immense debt of gratitude to my doctoral mentor, Dr. Arnold Nelson. His wealth of experience, unique perspectives, sharp intellect, and patient guidance were all instrumental in allowing this project to progress to completion.
    [Show full text]
  • The Crosstalk Between O-Glcnacylation and Phosphorylation in Insulin Signaling
    THE CROSSTALK BETWEEN O-GLCNACYLATION AND PHOSPHORYLATION IN INSULIN SIGNALING by Ping Hu A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland December, 2015 © Ping Hu All Rights Reserved ABSTRACT Extensive crosstalk between phosphorylation and O-GlcNAcylation is involved in regulating insulin signaling. In addition, many of the key regulators of insulin signaling have been shown to be O-GlcNAcylated. In this study, we first explored the crosstalk between phosphorylation and O-GlcNAcylation globally, and then focused on an upstream signaling regulator key to insulin signaling, insulin receptor substrate 1, IRS1. Through regulating cellular O-GlcNAcylation levels in differentiated adipocyte 3T3-L1 cells by specific OGT and OGA inhibitors, we measured the affects of O-GlcNAcylation on the phosphorylation status of key molecules. We observed that O-GlcNAcylation regulates the flux through the two main divergent cellular pathways of insulin signaling, one regulating glucose metabolism and the other regulating cellular proliferation via MAP kinase. Decreased O-GlcNAcylation was associated with increased glucose utilization, and increased O-GlcNAcylation was associated with increased insulin-induced cellular proliferation pathways. Since IRS1 is early in the insulin signaling pathway and is both highly O-GlcNAcylated and highly phosphorylated, we focused on the crosstalk of those two PTMs on IRS1. The phosphorylation spectrum of IRS1 revealed by 2D electrophoretic analyses, partially explained why decreased O-GlcNAcylation facilitated glucose uptake. Two new O- GlcNAcylation sites were mapped through CID/ETD mass spectrometry. With help of protein truncation and site mutagenesis techniques, we propose a mechanism suggesting that the O-GlcNAcylation of Ser635, may be a negative regulator of the C-terminal O- GlcNAcylations on IRS1.
    [Show full text]